Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Aug 5, 2022
- Accession no.
- 0001447362-22-000131
- Filed
- Aug 5, 2022
- Trade date
- Aug 3-4, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 21 non-derivative transactions. Open-market sales total $259.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | Common Stock | SSaleDisposed | −42 | $30.03F2 | −$1,261.26 | 328,661 | Direct | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −21 | $30.03F2 | −$630.63 | 148,671 | Indirect | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −21 | $30.03F2 | −$630.63 | 136,194 | Indirect | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −4 | $30.03F2 | −$120.12 | 30,167 | Indirect | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −4 | $30.03F2 | −$120.12 | 30,166 | Indirect | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −4 | $30.03F2 | −$120.12 | 30,166 | Indirect | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −4 | $30.03F2 | −$120.12 | 30,166 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −2,526 | $30.60F9 | −$77,295.6 | 326,135 | Direct | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −1,263 | $30.60F9 | −$38,647.8 | 147,408 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −1,263 | $30.60F9 | −$38,647.8 | 134,931 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −253 | $30.60F9 | −$7,741.8 | 29,914 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −254 | $30.60F9 | −$7,772.4 | 29,912 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −254 | $30.60F9 | −$7,772.4 | 29,912 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −253 | $30.60F9 | −$7,741.8 | 29,913 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −951 | $31.11F10 | −$29,585.61 | 325,184 | Direct | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −476 | $31.11F10 | −$14,808.36 | 146,932 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −476 | $31.11F10 | −$14,808.36 | 134,455 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −95 | $31.11F10 | −$2,955.45 | 29,819 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −95 | $31.11F10 | −$2,955.45 | 29,817 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −95 | $31.11F10 | −$2,955.45 | 29,817 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −96 | $31.11F10 | −$2,986.56 | 29,817 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $30.020 to $30.030, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $30.000 to $30.995, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $31.000 to $31.250, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.